On July 202, 2023, AcelRx Pharmaceuticals, Inc. closed the transaction. The transaction included participation from 10 investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 USD | -6.25% | +6.06% | +42.86% |
Mar. 06 | Talphera, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 06 | Transcript : Talphera, Inc., Q4 2023 Earnings Call, Mar 06, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.86% | 17.82M | |
+5.31% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
+18.82% | 2.38B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B |
- Stock Market
- Equities
- TLPH Stock
- News Talphera, Inc.
- AcelRx Pharmaceuticals, Inc. announced that it has received $9.997996 million in funding